Benralizumab Phase II COPD study published in The Lancet Respiratory Medicine
8 September 2014 | By AstraZeneca
Results are among key AstraZeneca respiratory data being presented at 2014 European Respiratory Society International Congress...
List view / Grid view
8 September 2014 | By AstraZeneca
Results are among key AstraZeneca respiratory data being presented at 2014 European Respiratory Society International Congress...
8 September 2014 | By GlaxoSmithKline
GSK presented data at the European Respiratory Society Congress that show blood eosinophil levels may help predict those patients with COPD who will have a greater reduction in exacerbation rates when receiving an inhaled corticosteroid containing regimen...
26 September 2012 | By GlaxoSmithKline
Japanese New Drug Application (JNDA) submitted for COPD and asthma....